SUMMARY Treatment of patients with coeliac disease with a low gluten containing diet (LGD) remains controversial. We have studied jejunal morphology and antigluten (AG) antibody titres by ELISA in patients on a LGD of 2.5-5 g/day for three to 14 months (median six months) and compared results with patients on a strict gluten free diet (GFD) for six to 27 months (median 13 months). We found no significant difference in villous height or crypt depth (eight LGD v 10 GFD patients) or serum AG-IgA, -IgG, and -IgM titres (13 LGD v 12 GFD patients). There was however, a significant increase (p<005) in intra-epithelial lymphocytes in those patients on a LGD. We conclude that adult coeliac patients can tolerate a LGD without gross morphological change and without initiating significant AG antibody responses.
After the discovery that gluten is involved in the pathogenesis of coeliac disease,' the medical profession has maintained that a life long strict gluten free diet is mandatory for the health of all patients. ' Although there is no doubt that dietary gluten withdrawal results in improvement of clinical symptoms and jejunal morphology, the necessity for total dietary gluten exclusion has been challenged. 4 Furthermore, despite physicians' recommendations, many patients are unable to maintain a restrictive GFD and continue to ingest small quantities of gluten.`5 A proportion of these patients remain asymptomatic with normal haematological and biochemical parameters. 7 In view of these findings we believe that a low gluten containing diet (LGD) may be a more realistic treatment for coeliac disease in some patients. This concept, however, remains controversial. 9 The aim of the present study was to determine the effects of a LGD on jejunal morphology and serum antibody levels to gluten in a group of coeliac patients we have maintained on a controlled LGD. Address (Fig.  1) . Some patients on a gluten free diet had low villous heights suggesting that they were in fact not adhering to a strict gluten free diet despite stating that they were.
Crypt depth was increased (p<0.01) in (Fig. 2) .
ANTIGLUTEN ANTIBODY TITRES
AG-IgA titres in the control group were in the range 0-800 (median 200). Titres were raised in 11 of the 13 untreated coeliac patients (median titre, 1600; range 200-3200), but decreased after treatment and a strict GFD (200; 0-800; p<0-01). There was no difference in AG-IgA titres between GFD patients, LGD patients (200; 0-3200) and control patients (Fig. 3) . One LGD patient had a persistently raised AG-IgA titre (3200), but subsequently admitted to ingesting more than 5 g gluten a day. In the patients put on a low gluten diet the serum folate fell from 14 pg/l (range 2.5 to 14.5) to 6-3 pg/I (range 2 to 8.4). In only one patient did it remain below normal before and after the low gluten study started suggesting previous ingestion of gluten. The 
